{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:41:31Z","timestamp":1790905291939,"version":"4.1.0"},"reference-count":72,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81661128041"],"award-info":[{"award-number":["81661128041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672019"],"award-info":[{"award-number":["81672019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822045"],"award-info":[{"award-number":["81822045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31600619"],"award-info":[{"award-number":["31600619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"publisher","award":["2016YFC1201000"],"award-info":[{"award-number":["2016YFC1201000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"publisher","award":["2016YFC1202901"],"award-info":[{"award-number":["2016YFC1202901"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Shanghai Rising-Star Program","award":["16QA1400300"],"award-info":[{"award-number":["16QA1400300"]}]},{"DOI":"10.13039\/501100018536","name":"National Megaprojects of China for Major Infectious Diseases","doi-asserted-by":"crossref","award":["2018ZX10301403"],"award-info":[{"award-number":["2018ZX10301403"]}],"id":[{"id":"10.13039\/501100018536","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Sanming Project of Medicine in Shenzhen"},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"publisher","award":["2016YFC1200405"],"award-info":[{"award-number":["2016YFC1200405"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,4,5]]},"abstract":"<jats:p>EK1 is a broad-spectrum human coronavirus fusion inhibitor for combating infection of current and emerging coronaviruses.<\/jats:p>","DOI":"10.1126\/sciadv.aav4580","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T23:14:10Z","timestamp":1554938050000},"source":"Crossref","is-referenced-by-count":458,"title":["A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-4182","authenticated-orcid":true,"given":"Shuai","family":"Xia","sequence":"first","affiliation":[{"name":"Shanghai Public Health Clinical Center and School of Basic Medical Sciences, and Key Laboratory of Medical Molecular Virology of MOE\/MOH, Fudan University, Shanghai 200032, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-5533","authenticated-orcid":true,"given":"Lei","family":"Yan","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-7182","authenticated-orcid":true,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center and School of Basic Medical Sciences, and Key Laboratory of Medical Molecular Virology of MOE\/MOH, Fudan University, Shanghai 200032, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurodh Shankar","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Algaissi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA."},{"name":"Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te K.","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center and School of Basic Medical Sciences, and Key Laboratory of Medical Molecular Virology of MOE\/MOH, Fudan University, Shanghai 200032, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[{"name":"MOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2419","authenticated-orcid":true,"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China."},{"name":"Department of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC206, La Jolla, CA 92037, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-6523","authenticated-orcid":true,"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center and School of Basic Medical Sciences, and Key Laboratory of Medical Molecular Virology of MOE\/MOH, Fudan University, Shanghai 200032, China."},{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-3859","authenticated-orcid":true,"given":"Bei","family":"Yang","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0391","authenticated-orcid":true,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center and School of Basic Medical Sciences, and Key Laboratory of Medical Molecular Virology of MOE\/MOH, Fudan University, Shanghai 200032, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06540-11"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.03.003"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.20595","article-title":"Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229E infection","volume":"42","author":"Simon A.","year":"2007","unstructured":"A. Simon, S. V\u00f6lz, K. H\u00f6fling, A. Kehl, R. Tillman, A. M\u00fcller, B. Kupfer, A.-M. Eis-H\u00fcbinger, M. J. Lentze, U. Bode, O. Schildgen, Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229E infection. Pediatr. Pulmonol. 42, 393\u2013396 (2007).","journal-title":"Pediatr. Pulmonol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMc1509458","article-title":"Human coronavirus OC43 associated with fatal encephalitis","volume":"375","author":"Morfopoulou S.","year":"2016","unstructured":"S. Morfopoulou, J. R. Brown, E. G. Davies, G. Anderson, A. Virasami, W. Qasim, W. K. Chong, M. Hubank, V. Plagnol, M. Desforges, T. S. Jacques, P. J. Talbot, J. Breuer, Human coronavirus OC43 associated with fatal encephalitis. N. Engl. J. Med. 375, 497\u2013498 (2016).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ejh.12744","article-title":"Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL","volume":"97","author":"Mayer K.","year":"2016","unstructured":"K. Mayer, C. Nellessen, C. Hahn-Ast, M. Schumacher, S. Pietzonka, A. M. Eis-H\u00fcbinger, C. Drosten, P. Brossart, D. Wolf, Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL. Eur. J. Haematol. 97, 208\u2013210 (2016).","journal-title":"Eur. J. Haematol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12985-016-0488-4","article-title":"Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia","volume":"13","author":"Al-Khannaq M. N.","year":"2016","unstructured":"M. N. Al-Khannaq, K. T. Ng, X. Y. Oong, Y. K. Pang, Y. Takebe, J. B. Chook, N. S. Hanafi, A. Kamarulzaman, K. K. Tee, Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol. J. 13, 33 (2016).","journal-title":"Virol. J."},{"key":"e_1_3_2_8_2","first-page":"e3","article-title":"Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: Phylogenetic, spatiotemporal and transmission network analyses","volume":"6","author":"Oong X. Y.","year":"2017","unstructured":"X. Y. Oong, K. T. Ng, Y. Takebe, L. J. Ng, K. G. Chan, J. B. Chook, A. Kamarulzaman, K. K. Tee, Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: Phylogenetic, spatiotemporal and transmission network analyses. Emerg. Microbes Infect. 6, e3 (2017).","journal-title":"Emerg. Microbes Infect."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1128\/JVI.05512-11","article-title":"Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination","volume":"85","author":"Lau S. K. P.","year":"2011","unstructured":"S. K. P. Lau, P. Lee, A. K. L. Tsang, C. C. Y. Yip, H. Tse, R. A. Lee, L.-Y. So, Y.-L. Lau, K.-H. Chan, P. C. Y. Woo, K.-Y. Yuen, Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J. Virol. 85, 11325\u201311337 (2011).","journal-title":"J. Virol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3985"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12711"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1517719113"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01279-15"},{"key":"e_1_3_2_14_2","first-page":"e35","article-title":"Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5","volume":"1","author":"Woo P. C. Y.","year":"2012","unstructured":"P. C. Y. Woo, S. K. P. Lau, K. S. M. Li, A. K. L. Tsang, K.-Y. Yuen, Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg. Microbes Infect. 1, e35 (2012).","journal-title":"Emerg. Microbes Infect."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: Spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu G.","year":"2015","unstructured":"G. Lu, Q. Wang, G. F. Gao, Bat-to-human: Spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 23, 468\u2013478 (2015).","journal-title":"Trends Microbiol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.virusres.2014.10.007","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein","volume":"194","author":"Xia S.","year":"2014","unstructured":"S. Xia, Q. Liu, Q. Wang, Z. Sun, S. Su, L. Du, T. Ying, L. Lu, S. Jiang, Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 194, 200\u2013210 (2014).","journal-title":"Virus Res."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/emi.2012.1","article-title":"Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines","volume":"1","author":"Jiang S.","year":"2012","unstructured":"S. Jiang, L. Lu, Q. Liu, W. Xu, L. Du, Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines. Emerg. Microbes Infect. 1, e13 (2012).","journal-title":"Emerg. Microbes Infect."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness","volume":"88","author":"Sui J.","year":"2014","unstructured":"J. Sui, M. Deming, B. Rockx, R. C. Liddington, Q. K. Zhu, R. S. Baric, W. A. Marasco, Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness. J. Virol. 88, 13769\u201313780 (2014).","journal-title":"J. Virol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15788-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/365113a0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human-immunodeficiency-virus type 1 gp41 are potent inhibitors of virus-infection","volume":"91","author":"Wild C. T.","year":"1994","unstructured":"C. T. Wild, D. C. Shugars, T. K. Greenwell, C. B. Mcdanal, T. J. Matthews, Peptides corresponding to a predictive alpha-helical domain of human-immunodeficiency-virus type 1 gp41 are potent inhibitors of virus-infection. Proc. Natl. Acad. Sci. U.S.A. 91, 9770\u20139774 (1994).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/07391102.1997.10508958","article-title":"A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein","volume":"15","author":"Lu M.","year":"1997","unstructured":"M. Lu, P. S. Kim, A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein. J. Biomol. Struct. Dynam. 15, 465\u2013471 (1997).","journal-title":"J. Biomol. Struct. Dynam."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"11684","DOI":"10.1021\/bi000471y","article-title":"Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex","volume":"39","author":"Lawless-Delmedico M. K.","year":"2000","unstructured":"M. K. Lawless-Delmedico, P. Sista, R. Sen, N. C. Moore, J. B. Antczak, J. M. White, R. J. Greene, K. C. Leanza, T. J. Matthews, D. M. Lambert, Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. Biochemistry 39, 11684\u201311695 (2000).","journal-title":"Biochemistry"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.21.10194-10201.2000"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.15.4024"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1743-422X-2-57","article-title":"Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein","volume":"2","author":"Bossart K. N.","year":"2005","unstructured":"K. N. Bossart, B. A. Mungall, G. Crameri, L.-F. Wang, B. T. Eaton, C. C. Broder, Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virol. J. 2, 57 (2005).","journal-title":"Virol. J."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.8801-8811.2003"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4067"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/pro.2442","article-title":"Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design","volume":"23","author":"Aydin H.","year":"2014","unstructured":"H. Aydin, D. Al-Khooly, J. E. Lee, Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design. Protein Sci. 23, 603\u2013617 (2014).","journal-title":"Protein Sci."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1021\/bi061686w","article-title":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein","volume":"45","author":"Zheng Q.","year":"2006","unstructured":"Q. Zheng, Y. Deng, J. Liu, L. van der Hoek, B. Berkhout, M. Lu, Core structure of S2 from the human coronavirus NL63 spike glycoprotein. Biochemistry 45, 15205\u201315215 (2006).","journal-title":"Biochemistry"},{"key":"e_1_3_2_31_2","first-page":"2937","article-title":"Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells","volume":"41","author":"Otaka A.","year":"2002","unstructured":"A. Otaka, M. Nakamura, D. Nameki, E. Kodama, S. Uchiyama, S. Nakamura, H. Nakano, H. Tamamura, Y. Kobayashi, M. Matsuoka, N. Fujii, Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells. Angew. Chem. Int. Ed. 41, 2937\u20132940 (2002).","journal-title":"Angew. Chem. Int. Ed."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.84.24.8898","article-title":"Helix stabilization by Glu-\u2026Lys+ salt bridges in short peptides of de novo design","volume":"84","author":"Marqusee S.","year":"1987","unstructured":"S. Marqusee, R. L. Baldwin, Helix stabilization by Glu-\u2026Lys+ salt bridges in short peptides of de novo design. Proc. Natl. Acad. Sci. U.S.A. 84, 8898\u20138902 (1987).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1116480"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/infdis\/jiv325","article-title":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection","volume":"212","author":"Channappanavar R.","year":"2015","unstructured":"R. Channappanavar, L. Lu, S. Xia, L. Du, D. K. Meyerholz, S. Perlman, S. Jiang, Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection. J. Infect. Dis. 212, 1894\u20131903 (2015).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt745"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2004.07.015","article-title":"HIV-1 virion fusion assay: Uncoating not required and no effect of Nef on fusion","volume":"328","author":"Cavrois M.","year":"2004","unstructured":"M. Cavrois, J. Neidleman, W. Yonemoto, D. Fenard, W. C. Greene, HIV-1 virion fusion assay: Uncoating not required and no effect of Nef on fusion. Virology 328, 36\u201344 (2004).","journal-title":"Virology"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","article-title":"Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha","volume":"79","author":"Yonezawa A.","year":"2005","unstructured":"A. Yonezawa, M. Cavrois, W. C. Greene, Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J. Virol. 79, 918\u2013926 (2005).","journal-title":"J. Virol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1743-422X-6-119","article-title":"A catalytically and genetically optimized \u03b2-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics","volume":"6","author":"Wolf M. C.","year":"2009","unstructured":"M. C. Wolf, Y. Wang, A. N. Freiberg, H. C. Aguilar, M. R. Holbrook, B. Lee, A catalytically and genetically optimized \u03b2-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virol. J. 6, 119 (2009).","journal-title":"Virol. J."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1107\/S2059798318008318","article-title":"Crystal structure of the post-fusion core of the human coronavirus 229E spike protein at 1.86 \u00c5 resolution","volume":"74","author":"Yan L.","year":"2018","unstructured":"L. Yan, B. Meng, J. Xiang, I. A. Wilson, B. Yang, Crystal structure of the post-fusion core of the human coronavirus 229E spike protein at 1.86 \u00c5 resolution. Acta Crystallogr. D 74, 841\u2013851 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00912-14"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"e01651-16","DOI":"10.1128\/JVI.01651-16","article-title":"Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants","volume":"91","author":"Tai W.","year":"2017","unstructured":"W. Tai, Y. Wang, C. A. Fett, G. Zhao, F. Li, S. Perlman, S. Jiang, Y. Zhou, L. Du, Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants. J. Virol. 91, e01651-16 (2017).","journal-title":"J. Virol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"e02002-17","DOI":"10.1128\/JVI.02002-17","article-title":"Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV spike glycoprotein to avoid neutralization escape","volume":"92","author":"Wang L.","year":"2018","unstructured":"L. Wang, W. Shi, J. D. Chappell, M. G. Joyce, Y. Zhang, M. Kanekiyo, M. M. Becker, N. van Doremalen, R. Fischer, N. Wang, K. S. Corbett, M. Choe, R. D. Mason, J. G. Van Galen, T. Zhou, K. O. Saunders, K. M. Tatti, L. M. Haynes, P. D. Kwong, K. Modjarrad, W.-P. Kong, J. S. McLellan, M. R. Denison, V. J. Munster, J. R. Mascola, B. S. Graham, Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV spike glycoprotein to avoid neutralization escape. J. Virol. 92, e02002-17 (2018).","journal-title":"J. Virol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/JVI.02615-14","article-title":"Receptor recognition mechanisms of coronaviruses: A decade of structural studies","volume":"89","author":"Li F.","year":"2015","unstructured":"F. Li, Receptor recognition mechanisms of coronaviruses: A decade of structural studies. J. Virol. 89, 1954\u20131964 (2015).","journal-title":"J. Virol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch B. J.","year":"2004","unstructured":"B. J. Bosch, B. E. E. Martina, R. van der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. R. Heck, R. de Groot, A. D. M. E. Osterhaus, P. J. M. Rottier, Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. U.S.A. 101, 8455\u20138460 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1074\/jbc.M609148200","article-title":"HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides","volume":"282","author":"Liu S.","year":"2007","unstructured":"S. Liu, W. Jing, B. Cheung, H. Lu, J. Sun, X. Yan, J. Niu, J. Farmar, S. Wu, S. Jiang, HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides. J. Biol. Chem. 282, 9612\u20139620 (2007).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1021\/acs.jmedchem.8b00890","article-title":"De novo design of \u03b1-helical lipopeptides targeting viral fusion proteins: A promising strategy for relatively broad-spectrum antiviral drug discovery","volume":"61","author":"Wang C.","year":"2018","unstructured":"C. Wang, L. Zhao, S. Xia, T. Zhang, R.-Y. Cao, G. Liang, Y. Li, G. Meng, W. Wang, W. Shi, W. Zhong, S. Jiang, K. Liu, De novo design of \u03b1-helical lipopeptides targeting viral fusion proteins: A promising strategy for relatively broad-spectrum antiviral drug discovery. J. Med. Chem. 61, 8734\u20138745 (2018).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.jmedchem.7b01732","article-title":"Discovery of hydrocarbon-stapled short \u03b1-helical peptides as promising middle east respiratory syndrome coronavirus (MERS-CoV) fusion inhibitors","volume":"61","author":"Wang C.","year":"2018","unstructured":"C. Wang, S. Xia, P. Zhang, T. Zhang, W. Wang, Y. Tian, G. Meng, S. Jiang, K. Liu, Discovery of hydrocarbon-stapled short \u03b1-helical peptides as promising middle east respiratory syndrome coronavirus (MERS-CoV) fusion inhibitors. J. Med. Chem. 61, 2018\u20132026 (2018).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01542-10"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006546"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram S.","year":"2011","unstructured":"S. Bertram, I. Glowacka, M. A. M\u00fcller, H. Lavender, K. Gnirss, I. Nehlmeier, D. Niemeyer, Y. He, G. Simmons, C. Drosten, E. J. Soilleux, O. Jahn, I. Steffen, S. P\u00f6hlmann, Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 85, 13363\u201313372 (2011).","journal-title":"J. Virol."},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.molmed.2009.05.003","article-title":"Type II transmembrane serine proteases in cancer and viral infections","volume":"15","author":"Choi S.-Y.","year":"2009","unstructured":"S.-Y. Choi, S. Bertram, I. Glowacka, Y. W. Park, S. P\u00f6hlmann, Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15, 303\u2013312 (2009).","journal-title":"Trends Mol. Med."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"e01387-16","DOI":"10.1128\/JVI.01387-16","article-title":"Clinical isolates of human coronavirus 229E bypass the endosome for cell entry","volume":"91","author":"Shirato K.","year":"2017","unstructured":"K. Shirato, K. Kanou, M. Kawase, S. Matsuyama, Clinical isolates of human coronavirus 229E bypass the endosome for cell entry. J. Virol. 91, e01387-16 (2017).","journal-title":"J. Virol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.11.012"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/430301","article-title":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China","volume":"40","author":"Chiu S. S.","year":"2005","unstructured":"S. S. Chiu, K. H. Chan, K. W. Chu, S. W. Kwan, Y. Guan, L. L. M. Poon, J. S. M. Peiris, Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 40, 1721\u20131729 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/597122","article-title":"Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease","volume":"199","author":"Gorse G. J.","year":"2009","unstructured":"G. J. Gorse, T. Z. O'Connor, S. L. Hall, J. N. Vitale, K. L. Nichol, Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease. J. Infect. Dis. 199, 847\u2013857 (2009).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/INF.0b013e3182812787","article-title":"Severity and outcome associated with human coronavirus OC43 infections among children","volume":"32","author":"Jean A.","year":"2013","unstructured":"A. Jean, C. Quach, A. Yung, M. Semret, Severity and outcome associated with human coronavirus OC43 infections among children. Pediatr. Infect. Dis. J. 32, 325\u2013329 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15672"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(97)76066-X"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909052925"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444904019158"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909042073"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh381"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku340"},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1021\/bi00713a027","article-title":"Determination of the helix and beta form of proteins in aqueous solution by circular dichroism","volume":"13","author":"Chen Y. H.","year":"1974","unstructured":"Y. H. Chen, J. T. Yang, K. H. Chau, Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 13, 3350\u20133359 (1974).","journal-title":"Biochemistry"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.peptides.2003.07.013","article-title":"Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: Applicable for identification of HIV-1 fusion inhibitors","volume":"24","author":"Liu S. W.","year":"2003","unstructured":"S. W. Liu, Q. Zhao, S. B. Jiang, Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: Applicable for identification of HIV-1 fusion inhibitors. Peptides 24, 1303\u20131313 (2003).","journal-title":"Peptides"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1128\/JVI.02972-13","article-title":"Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus","volume":"88","author":"Brison E.","year":"2014","unstructured":"E. Brison, H. Jacomy, M. Desforges, P. J. Talbot, Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus. J. Virol. 88, 1548\u20131563 (2014).","journal-title":"J. Virol."},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.msec.2017.03.047","article-title":"Biopolymeric nano\/microspheres for selective and reversible adsorption of coronaviruses","volume":"76","author":"Ciejka J.","year":"2017","unstructured":"J. Ciejka, K. Wolski, M. Nowakowska, K. Pyrc, K. Szczubia\u0142ka, Biopolymeric nano\/microspheres for selective and reversible adsorption of coronaviruses. Mater. Sci. Eng. C Mater. Biol. Appl. 76, 735\u2013742 (2017).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03001-13"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01562-13"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0042-6822(03)00323-4","article-title":"Vacuolating encephalitis in mice infected by human coronavirus OC43","volume":"315","author":"Jacomy H.","year":"2003","unstructured":"H. Jacomy, P. J. Talbot, Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology 315, 20\u201333 (2003).","journal-title":"Virology"},{"key":"e_1_3_2_72_2","first-page":"5471","article-title":"Pharmacokinetics on a microscale: Visualizing Cy5-labeled oligonucleotide release from poly(n- butylcyanoacrylate) nanocapsules in cells","volume":"9","author":"Tomcin S.","year":"2014","unstructured":"S. Tomcin, G. Baier, K. Landfester, V. Mail\u00e4nder, Pharmacokinetics on a microscale: Visualizing Cy5-labeled oligonucleotide release from poly(n- butylcyanoacrylate) nanocapsules in cells. Int. J. Nanomedicine 9, 5471\u20135489 (2014).","journal-title":"Int. J. Nanomedicine"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0635-y"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aav4580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:39:40Z","timestamp":1704821980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aav4580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,5]]}},"alternative-id":["10.1126\/sciadv.aav4580"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aav4580","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"article-number":"eaav4580"}}